Auxilium Pharmaceuticals Inc (NASDAQ:AUXL)
| 15.01 Data as of May 17 |  -0.04 / -0.27%Today’s Change | 13.87 Today|||52-Week Range 29.37 | -19.04% Year-to-Date |
Latest AUXL News | Press Releases
No recent news for Auxilium Pharmaceuticals Inc.
Today’s Trading
| Previous close | 15.05 |
| Today’s open | 15.09 |
| Day’s range | 14.99 - 15.34 |
| Volume | 828,141 |
| Average volume (3 months) | 787,754 |
| Market cap | $742.1M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -105.92% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +49.55% |
| P/E ratio | 9.3 |
| Price/Sales | 2.29 |
| Price/Book | 3.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OPTROptimer Pharmaceutic... | -0.14 | -0.93% |
| ACHNAchillion Pharmaceut... | +0.21 | +2.78% |
| CBPOChina Biologic Produ... | +0.34 | +1.30% |
| NBIXNeurocrine Bioscienc... | -0.24 | -2.00% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $395.3M |
| Annual profit (last year) | $85.9M |
| Net profit margin | 21.74% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Adrian Adams |
Chief Financial Officer & Head-Investor Relations James E. Fickenscher, CPA |
Corporate headquarters Chesterbrook, Pennsylvania |
Forecasts
